Evidence map›Paper›PMID 32849775›Full record

ArticleFrontiers in genetics2020

Corrigendum: Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells.

Nunzia Mollo, Maria Nitti, Lucrezia Zerillo, Deriggio Faicchia, Teresa Micillo, Rossella Accarino, Agnese Secondo, Tiziana Petrozziello, Gaetano Calì, Rita Cicatiello and 9 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Nunzia MolloDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Maria NittiDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Lucrezia ZerilloDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Deriggio FaicchiaInstitute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy.
Teresa MicilloDepartment of Biology, University of Naples Federico II, Naples, Italy.
Rossella AccarinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Agnese SecondoDepartment of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Tiziana PetrozzielloDepartment of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Gaetano CalìInstitute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy.
Rita CicatielloDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Ferdinando BonfiglioDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Viviana SarnataroDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Rita GenesioDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Antonella IzzoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Paolo PintonDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Giuseppe MatareseDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Simona PaladinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Anna ContiDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Lucio NitschDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
University of Naples Federico II · ITNational Research Council · ITInstitute for Experimental Endocrinology and Oncology · ITUniversity of Basel · CHUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fgene.2019.00606.].

Indexed as

Down syndrome/therapyenergy metabolismmitochondrial dynamicsmitochondrial dysfunctionoxidative stresspioglitazone

Identifiers

PMID32849775
PMCPMC7398157
OpenAlexW3037948099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.